The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation

Journal of Physiology

Volumn 594, Issue 21, 2016, Pages 6189-6209

  Sandison, Mairi E ^a   Dempster, John ^a   McCarron, John G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

phenotypic modulation; vascular remodeling; vascular smooth muscle

Indexed keywords

CD68 ANTIGEN; GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL MIGRATION; CONTROLLED STUDY; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MICROSCOPY; MODULATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CELL; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MUSCLE CONTRACTION; SPRAGUE DAWLEY RAT; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; GUINEA PIGS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHAGOCYTOSIS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR REMODELING;

EID: 84981306927     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP272729     Document Type: Article

References (80)

1. Abounit S & Zurzolo C (2012). Wiring through tunneling nanotubes – from electrical signals to organelle transfer. J Cell Sci 125, 1089–1098.
2. Allahverdian S, Chehroudi AC, McManus BM, Abraham T & Francis GA (2014). Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129, 1551–1559.
3. Andreeva ER, Pugach IM & Orekhov AN (1997). Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 135, 19–27.
4. Ankrum JA, Miranda OR, Ng KS, Sarkar D, Xu C & Karp JM (2014). Engineering cells with intracellular agent-loaded microparticles to control cell phenotype. Nat Protoc 9, 233–245.
5. Arciniegas E, Sutton AB, Allen TD & Schor AM (1992). Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 103, 521–529.
6. Arlein WJ, Shearer JD & Caldwell MD (1998). Continuity between wound macrophage and fibroblast phenotype: analysis of wound fibroblast phagocytosis. Am J Physiol Regul Integr Comp Physiol 275, R1041–R1048.
7. Bahadory F, Moore KH, Liu L & Burcher E (2013). Gene expression of muscarinic, tachykinin, and purinergic receptors in porcine bladder: comparison with cultured cells. Front Pharmacol 4, 148.
8. Basson CT, Kocher O, Basson MD, Asis A & Madri JA (1992). Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration. J Cell Physiol 153, 118–128.
9. Bennett MR, Sinha S & Owens GK (2016). Vascular smooth muscle cells in atherosclerosis. Circ Res 118, 692–702.
10. Bobryshev YV, Killingsworth MC & Orekhov AN (2013). Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage. Pathobiology 80, 24–31.
11. Bochaton-Piallat ML, Ropraz P, Gabbiani F & Gabbiani G (1996). Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 16, 815–820.
12. Boselli C, Govoni S, Vicini D, Lanni C, Racchi M & D'Agostino G (2002). Presence and passage dependent loss of biochemical M3 muscarinic receptor function in human detrusor cultured smooth muscle cells. J Urol 168, 2672–2676.
13. Boulanger CM (2010). Microparticles, vascular function and hypertension. Current Opin Nephrol Hypertens 19, 177–180.
14. 2+ removal in smooth muscle. J Cell Sci 116, 4291–4306.
15. Campbell GR & Campbell JH (1990). The phenotypes of smooth muscle expressed in human atheroma. Ann N Y Acad Sci 598, 143–158.
16. Campbell JH & Campbell GR (2012). Smooth muscle phenotypic modulation – a personal experience. Arterioscler Thromb Vasc Biol 32, 1784–1789.
17. Campbell JH, Kocher O, Skalli O, Gabbiani G & Campbell GR (1989). Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 9, 633–643.
18. Chaar V, Romana M, Tripette J, Broquere C, Huisse MG, Hue O, Hardy-Dessources MD & Connes P (2011). Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc 47, 15–25.
19. Chalmers S, Saunter C, Wilson C, Coats P, Girkin JM & McCarron JG (2012). Mitochondrial motility and vascular smooth muscle proliferation. Arterioscler Thromb Vasc Biol 32, 3000–3011.
20. Clowes AW, Reidy MA & Clowes MM (1983). Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49, 327–333.
21. Davis DM & Sowinski S (2008). Membrane nanotubes: dynamic long-distance connections between animal cells. Nat Rev Mol Cell Biol 9, 431–436.
22. Ennes HS, McRoberts JA, Hyman PE & Snape WJ Jr (1992). Characterization of colonic circular smooth muscle cells in culture. Am J Physiol Gastrointest Liver Physiol 263, G365–G370.
23. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M & Feil R (2014). Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res 115, 662–667.
24. Feil S, Hofmann F & Feil R (2004). SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res 94, 863–865.
25. Gerdes HH & Carvalho RN (2008). Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol 20, 470–475.
26. Glukhova MA, Kabakov AE, Frid MG, Ornatsky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE & Smirnov VN (1988). Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 85, 9542–9546.
27. Gomez D, Shankman LS, Nguyen AT & Owens GK (2013). Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 10, 171–177.
28. Gonzalez MC, Arribas SM, Molero F & Fernandez-Alfonso MS (2001). Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol 280, H2876–H2881.
29. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, Olivo-Marin JC, Mannel D & Zurzolo C (2009). Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11, 328–336.
30. Hao H, Ropraz P, Verin V, Camenzind E, Geinoz A, Pepper MS, Gabbiani G & Bochaton-Piallat ML (2002). Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 22, 1093–1099.
31. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J & Seidel C (1996). Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest 97, 814–825.
32. Jiang H & Grinnell F (2005). Cell-matrix entanglement and mechanical anchorage of fibroblasts in three-dimensional collagen matrices. Mol Biol Cell 16, 5070–5076.
33. Kadiu I & Gendelman HE (2011a). Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection. J Neuroimmune Pharmacol 6, 658–675.
34. Kadiu I & Gendelman HE (2011b). Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi network. J Proteome Res 10, 3225–3238.
35. 2+ removal mechanisms in rat cerebral resistance size arteries. Biophys J 75, 1767–1773.
36. Karagianni F, Prakoura N, Kaltsa G, Politis P, Arvaniti E, Kaltezioti V, Psarras S, Pagakis S, Katsimboulas M, Abed A, Chatziantoniou C & Charonis A (2013). Transgelin up-regulation in obstructive nephropathy. PLoS One 8, e66887.
37. Koyanagi M, Brandes RP, Haendeler J, Zeiher AM & Dimmeler S (2005). Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ Res 96, 1039–1041.
38. Leclerc G, Isner JM, Kearney M, Simons M, Safian RD, Baim DS & Weir L (1992). Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation 85, 543–553.
39. Li H, Freeman MW & Libby P (1995). Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95, 122–133.
40. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM & Pickering JG (2001). Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 89, 517–525.
41. Li Z, Cheng H, Lederer WJ, Froehlich J & Lakatta EG (1997). Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp Mol Pathol 64, 1–11.
42. Ludin A, Itkin T, Gur-Cohen S, Mildner A, Shezen E, Golan K, Kollet O, Kalinkovich A, Porat Z, D'Uva G, Schajnovitz A, Voronov E, Brenner DA, Apte RN, Jung S & Lapidot T (2012). Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nature Immunol 13, 1072–1082.
43. 2+ store in guinea-pig colonic smooth muscle. J Physiol 516, 149–161.
44. Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I & Owens GK (1998). Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ Res 82, 908–917.
45. Margariti A, Zeng L & Xu Q (2006). Stem cells, vascular smooth muscle cells and atherosclerosis. Histol Histopathol 21, 979–985.
46. Martin K, Weiss S, Metharom P, Schmeckpeper J, Hynes B, O'Sullivan J & Caplice N (2009). Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ Res 105, 214–218.
47. Matsumoto K, Hirano K, Nozaki S, Takamoto A, Nishida M, Nakagawa-Toyama Y, Janabi MY, Ohya T, Yamashita S & Matsuzawa Y (2000). Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. Arterioscler Thromb Vasc Biol 20, 1027–1032.
48. Mause SF & Weber C (2010). Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107, 1047–1057.
49. Mietus-Snyder M, Gowri MS & Pitas RE (2000). Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. J Biol Chem 275, 17661–17670.
50. Moroianu J, Fett JW, Riordan JF & Vallee BL (1993). Actin is a surface component of calf pulmonary artery endothelial cells in culture. Proc Natl Acad Sci USA 90, 3815–3819.
51. Nguyen AT, Gomez D, Bell RD, Campbell JH, Clowes AW, Gabbiani G, Giachelli CM, Parmacek MS, Raines EW, Rusch NJ, Speer MY, Sturek M, Thyberg J, Towler DA, Weiser-Evans MC, Yan C, Miano JM & Owens GK (2013). Smooth muscle cell plasticity: fact or fiction? Circ Res 112, 17–22.
52. 2+ wave initiation in smooth muscle. J Cell Sci 125, 5315–5328.
53. Onfelt B, Nedvetzki S, Yanagi K & Davis DM (2004). Cutting edge: Membrane nanotubes connect immune cells. J Immunol 173, 1511–1513.
54. Pauletto P, Chiavegato A, Giuriato L, Scatena M, Faggin E, Grisenti A, Sarzani R, Paci MV, Fulgeri PD & Rappelli A (1994). Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype. Circ Res 74, 774–788.
55. 2+ store arrangement in vascular smooth muscle. Cell Calcium 46, 313–322.
56. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P & Ratajczak MZ (2006a). Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847–856.
57. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A & Ratajczak MZ (2006b). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487–1495.
58. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R & Swirski FK (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19, 1166–1172.
59. Rong JX, Shapiro M, Trogan E & Fisher EA (2003). Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100, 13531–13536.
60. Ross R (1999). Atherosclerosis – an inflammatory disease. N Engl J Med 340, 115–126.
61. Rustom A, Saffrich R, Markovic I, Walther P & Gerdes HH (2004). Nanotubular highways for intercellular organelle transport. Science 303, 1007–1010.
62. Sainz J, Zen AA, Caligiuri G, Demerens C, Urbain D, Lemitre M & Lafont A (2006). Isolation of “side population” progenitor cells from healthy arteries of adult mice. Arterioscl Throm Vas 26, 281–286.
63. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S & Pauletto P (2001). Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89, 1111–1121.
64. Sartore S, Franch R, Roelofs M & Chiavegato A (1999). Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol 134, 235–320.
65. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ & Owens GK (2015). KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 21, 628–637.
66. Shapland C, Lowings P & Lawson D (1988). Identification of new actin-associated polypeptides that are modified by viral transformation and changes in cell shape. J Cell Biol 107, 153–161.
67. Shen Z, Li C, Frieler RA, Gerasimova AS, Lee SJ, Wu J, Wang MM, Lumeng CN, Brosius FC 3rd, Duan SZ & Mortensen RM (2012). Smooth muscle protein 22 alpha-Cre is expressed in myeloid cells in mice. Biochem Biophys Res Commun 422, 639–642.
68. 2+ signals within tunneling membrane nanotubes. Biophys J 100, L37–39.
69. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Kohler K, Oddos S, Eissmann P, Brodsky FM, Hopkins C, Onfelt B, Sattentau Q & Davis DM (2008). Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 10, 211–219.
70. Stemerman MB & Ross R (1972). Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med 136, 769–789.
71. Stewart HJ, Guildford AL, Lawrence-Watt DJ & Santin M (2009). Substrate-induced phenotypical change of monocytes/macrophages into myofibroblast-like cells: a new insight into the mechanism of in-stent restenosis. J Biomed Mater Res A 90, 465–471.
72. Takahashi K, Takeya M & Sakashita N (2002). Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35, 179–203.
73. Tang Z, Wang A, Wang D & Li S (2013). Smooth muscle cells: to be or not to be? Response to Nguyen et al. Circ Res 112, 23–26.
74. Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu JS, Helms JA & Li S (2012). Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nature Commun 3, 875.
75. Varon D & Shai E (2009). Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 8, 237–241.
76. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM & Fisher EA (2015). Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol 35, 535–546.
77. Wang G, Jacquet L, Karamariti E & Xu Q (2015). Origin and differentiation of vascular smooth muscle cells. J Physiol 593, 3013–3030.
78. Wang X & Gerdes HH (2012). Long-distance electrical coupling via tunneling nanotubes. Biochim Biophys Acta 1818, 2082–2086.
79. Wang Y, Cui J, Sun X & Zhang Y (2011). Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ 18, 732–742.
80. Watkins SC & Salter RD (2005). Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23, 309–318.